A
Anjali
About Anjali
Data last updated:
Anjali is a Director at Ankran Biotech Private Limited (since 2018), Director at Vexxon Overseas Limited (since 2023) and Director at Amkon Pharmaceuticals Private Limited (since 2021). The companies operate in Pharma and Paper. The largest current company by reported revenue is Ankran Biotech Private Limited at ₹8.91 Cr (FY 2021).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Ankran Biotech Private Limited U51502PB2016PTC040130 | Director | 02 Aug 2018 | 2016 | ₹8.91 Cr (FY 2021) | Active |
 Vexxon Overseas Limited U21001HP2023PLC010508 | Director | 30 Nov 2023 | 2023 | Active | |
| Amkon Pharmaceuticals Private Limited U24249PB2021PTC053363 | Director | 10 May 2021 | 2021 | Active |
Board colleagues of Anjali
| Name | DIN | Company | Designation |
|---|---|---|---|
| Parminder Singh | 07415462 | Ankran Biotech Private Limited , Vexxon Overseas Limited and 1 more | Director |
| Sandeep Sharma | 08329899 | Vexxon Overseas Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Anjali
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anjali
Anjali currently holds 3 directorships: Ankran Biotech Private Limited (Director, since 02 Aug 2018, revenue ₹8.91 Cr (FY 2021)); Vexxon Overseas Limited (Director, since 30 Nov 2023); Amkon Pharmaceuticals Private Limited (Director, since 10 May 2021).
Anjali was first appointed on 02 Aug 2018 as Director at Ankran Biotech Private Limited. The most recent appointment on record is 30 Nov 2023 at Vexxon Overseas Limited.
The current boards of Anjali's companies include Parminder Singh (Ankran Biotech Private Limited), Sandeep Sharma (Vexxon Overseas Limited).